Literature DB >> 26371589

A toll-like receptor 9 (rs352140) variant is associated with placental inflammation in newborn infants.

Vijender Karody1, Shawn Reese2, Navin Kumar3, Jennifer Liedel4,5, Jason Jarzembowski6, Venkatesh Sampath1.   

Abstract

OBJECTIVE: Chorioamnionitis contributes to premature birth and associated postnatal morbidity. The genetic basis of altered immune responses underlying placental inflammation (PI) remains understudied. The aim of this study was to evaluate the relationship among TLR signaling pathway polymorphisms and different patterns of PI.
METHODS: Prospective cohort study in infants involving cord blood collection and placental examination for PI. One hundred and fifty-nine infants enrolled in study out of which 28 were term (eight with PI) and 131 preterm (47 with PI). DNA from blood was genotyped for SNPs in TLR2, 4, 5, 9, NFKBI, NFKBIA, TIRAP, and IRAK1 genes using multiplexed single base extension assay.
RESULTS: While there were no differences in BW, GA, gender, race, and SPL among infants with or without PI, there was a higher incidence of PPROM, maternal smoking, drug use, and clinical chorioamnionitis among infants with PI. Out of nine TLR variants, only CT and/or TT genotypes of the TLR9 variant (rs352140) were significantly associated (p = 0.004) with any PI and maternal pattern of inflammation (p = 0.012) both by univariate analysis and logistic regression.
CONCLUSIONS: The presence of a variant T allele in a common SNP (rs352140) in the TLR9 gene whose product recognizes bacterial DNA is associated with increased PI.

Entities:  

Keywords:  Chorioamnionitis; innate immunity; placental inflammation; rs352140; toll-like receptor 9 polymorphisms

Mesh:

Substances:

Year:  2015        PMID: 26371589      PMCID: PMC5238957          DOI: 10.3109/14767058.2015.1081590

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  37 in total

1.  Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance.

Authors:  Daniel A Kahn; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

2.  Maternal smoking and causes of very preterm birth.

Authors:  Nina B Kyrklund-Blomberg; Fredrik Granath; Sven Cnattingius
Journal:  Acta Obstet Gynecol Scand       Date:  2005-06       Impact factor: 3.636

Review 3.  Expression and function of toll-like receptors at the maternal-fetal interface.

Authors:  Kaori Koga; Gil Mor
Journal:  Reprod Sci       Date:  2008-04       Impact factor: 3.060

4.  Cocaine abuse during pregnancy: maternal and fetal implications.

Authors:  B B Little; L M Snell; V R Klein; L C Gilstrap
Journal:  Obstet Gynecol       Date:  1989-02       Impact factor: 7.661

5.  A TLR5 (g.1174C > T) variant that encodes a stop codon (R392X) is associated with bronchopulmonary dysplasia.

Authors:  Venkatesh Sampath; Jeffery S Garland; Min Le; Aloka L Patel; Girija G Konduri; Jonathan D Cohen; Pippa M Simpson; Ronald N Hines
Journal:  Pediatr Pulmonol       Date:  2011-11-04

6.  Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling.

Authors:  Prasad Rallabhandi; Jessica Bell; Marina S Boukhvalova; Andrei Medvedev; Eva Lorenz; Moshe Arditi; Val G Hemming; Jorge C G Blanco; David M Segal; Stefanie N Vogel
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

7.  Histological chorioamnionitis - implication for bacterial colonization, laboratory markers of infection, and early onset sepsis in very-low-birth-weight neonates.

Authors:  Shing Yan Robert Lee; Chi Wai Leung
Journal:  J Matern Fetal Neonatal Med       Date:  2011-05-24

8.  Toll-like receptor 9 activation: a novel mechanism linking placenta-derived mitochondrial DNA and vascular dysfunction in pre-eclampsia.

Authors:  Styliani Goulopoulou; Takayuki Matsumoto; Gisele F Bomfim; R Clinton Webb
Journal:  Clin Sci (Lond)       Date:  2012-10       Impact factor: 6.124

9.  The fetal inflammatory response in subgroups of women with preterm prelabor rupture of the membranes.

Authors:  Marian Kacerovsky; Teresa Cobo; Ctirad Andrys; Ivana Musilova; Marcela Drahosova; Helena Hornychova; Petr Janku; Bo Jacobsson
Journal:  J Matern Fetal Neonatal Med       Date:  2013-02-01

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  5 in total

1.  Effects of Single-Nucleotide Polymorphisms in Cytokine, Toll-Like Receptor, and Progesterone Receptor Genes on Risk of Miscarriage.

Authors:  Anastasiia Razdaibiedina; Mykhaylo Khobzey; Victoria Tkachenko; Iryna Vorobiova
Journal:  Obstet Gynecol Int       Date:  2018-07-17

2.  Association of a placental Interleukin-6 genetic variant (rs1800796) with DNA methylation, gene expression and risk of acute chorioamnionitis.

Authors:  Chaini Konwar; Giulia F Del Gobbo; Jefferson Terry; Wendy P Robinson
Journal:  BMC Med Genet       Date:  2019-02-22       Impact factor: 2.103

3.  Single Nucleotide Polymorphisms from CSF2, FLT1, TFPI and TLR9 Genes Are Associated with Prelabor Rupture of Membranes.

Authors:  Wioletta Izabela Wujcicka; Marian Kacerovsky; Michał Krekora; Piotr Kaczmarek; Mariusz Grzesiak
Journal:  Genes (Basel)       Date:  2021-10-28       Impact factor: 4.096

4.  Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.

Authors:  Madison R Chandler; Kimberly S Keene; Johanna M Tuomela; Andres Forero-Torres; Renee Desmond; Katri S Vuopala; Kevin W Harris; Nancy D Merner; Katri S Selander
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

5.  DNA methylation profiling of acute chorioamnionitis-associated placentas and fetal membranes: insights into epigenetic variation in spontaneous preterm births.

Authors:  Chaini Konwar; E Magda Price; Li Qing Wang; Samantha L Wilson; Jefferson Terry; Wendy P Robinson
Journal:  Epigenetics Chromatin       Date:  2018-10-29       Impact factor: 4.954

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.